FDA Officials Defend Use of Placebos During Ebola Drug Trials
November 6, 2014
(Los Angeles Times) – FDA officials speaking at a tropical medicine conference Wednesday said experimental Ebola drugs should be tested in randomized controlled trials — a “gold standard” form of drug assessment that involves giving some ill patients a sham treatment, or placebo. Addressing reporters at a session of the American Society of Tropical Medicine and Hygiene in New Orleans, U.S. Food and Drug Administration officials said randomized controlled trials were the only way to truly determine whether any of a number of experimental Ebola treatments were effective.